New Proteomics Technology Brings Unprecedented Sensitivity and Scale: Yuling Luo, CEO, Alamar Bio
www.mendelspod.com
Yuling Luo is a serial entrepreneur who has founded three significant companies in life science tools. Most recently, he is the founder and CEO of Alamar Biosciences which this year commercially launched its ARGO HT instrument as well as a powerful new panel to detect inflammatory proteins called NULISA.
New Proteomics Technology Brings Unprecedented Sensitivity and Scale: Yuling Luo, CEO, Alamar Bio
New Proteomics Technology Brings…
New Proteomics Technology Brings Unprecedented Sensitivity and Scale: Yuling Luo, CEO, Alamar Bio
Yuling Luo is a serial entrepreneur who has founded three significant companies in life science tools. Most recently, he is the founder and CEO of Alamar Biosciences which this year commercially launched its ARGO HT instrument as well as a powerful new panel to detect inflammatory proteins called NULISA.